Indication

Renal Osteodystrophy

2 clinical trials

1 product

1 drug

Clinical trial

Precision Medicine Approaches to Renal Osteodystrophy

Status: Recruiting, Estimated PCD: 2026-08-17

Product

Standard treatment for bone disorder

Clinical trial

Effect of Allopurinol on Markers of Mineral and Bone Metabolism in Patients in With Chronic Kidney Disease: a Randomized Double-blind Study

Status: Active (not recruiting), Estimated PCD: 2023-12-30

Drug